img

Global Gadolinium-Based Contrast Agents Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gadolinium-Based Contrast Agents Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Contrast Agents for MRI
The global Gadolinium-Based Contrast Agents market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Gadolinium-Based Contrast Agents is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Gadolinium-Based Contrast Agents include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Jiangsu Hengrui Medicine, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Gadolinium-Based Contrast Agents, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Gadolinium-Based Contrast Agents by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Gadolinium-Based Contrast Agents market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Gadolinium-Based Contrast Agents market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Jiangsu Hengrui Medicine
Marotrast
Agfa
Stary
By Type
Linear Gadolinium-Based Contrast Agents
Macrocycle Gadolinium-Based Contrast Agents
By Application
Hospital
Specialist Clinic
Others
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Gadolinium-Based Contrast Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Gadolinium-Based Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gadolinium-Based Contrast Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Gadolinium-Based Contrast Agents Definition
1.2 Market by Type
1.2.1 Global Gadolinium-Based Contrast Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Linear Gadolinium-Based Contrast Agents
1.2.3 Macrocycle Gadolinium-Based Contrast Agents
1.3 Market Segment by Application
1.3.1 Global Gadolinium-Based Contrast Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Gadolinium-Based Contrast Agents Sales
2.1 Global Gadolinium-Based Contrast Agents Revenue Estimates and Forecasts 2018-2034
2.2 Global Gadolinium-Based Contrast Agents Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Gadolinium-Based Contrast Agents Revenue by Region
2.3.1 Global Gadolinium-Based Contrast Agents Revenue by Region (2018-2024)
2.3.2 Global Gadolinium-Based Contrast Agents Revenue by Region (2024-2034)
2.4 Global Gadolinium-Based Contrast Agents Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Gadolinium-Based Contrast Agents Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Gadolinium-Based Contrast Agents Sales Quantity by Region
2.6.1 Global Gadolinium-Based Contrast Agents Sales Quantity by Region (2018-2024)
2.6.2 Global Gadolinium-Based Contrast Agents Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Gadolinium-Based Contrast Agents Sales Quantity by Manufacturers
3.1.1 Global Gadolinium-Based Contrast Agents Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Gadolinium-Based Contrast Agents Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Gadolinium-Based Contrast Agents Sales in 2022
3.2 Global Gadolinium-Based Contrast Agents Revenue by Manufacturers
3.2.1 Global Gadolinium-Based Contrast Agents Revenue by Manufacturers (2018-2024)
3.2.2 Global Gadolinium-Based Contrast Agents Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Gadolinium-Based Contrast Agents Revenue in 2022
3.3 Global Gadolinium-Based Contrast Agents Sales Price by Manufacturers
3.4 Global Key Players of Gadolinium-Based Contrast Agents, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gadolinium-Based Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Product Offered and Application
3.8 Global Key Manufacturers of Gadolinium-Based Contrast Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Gadolinium-Based Contrast Agents Sales Quantity by Type
4.1.1 Global Gadolinium-Based Contrast Agents Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Gadolinium-Based Contrast Agents Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
4.2 Global Gadolinium-Based Contrast Agents Revenue by Type
4.2.1 Global Gadolinium-Based Contrast Agents Historical Revenue by Type (2018-2024)
4.2.2 Global Gadolinium-Based Contrast Agents Forecasted Revenue by Type (2024-2034)
4.2.3 Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
4.3 Global Gadolinium-Based Contrast Agents Price by Type
4.3.1 Global Gadolinium-Based Contrast Agents Price by Type (2018-2024)
4.3.2 Global Gadolinium-Based Contrast Agents Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Gadolinium-Based Contrast Agents Sales Quantity by Application
5.1.1 Global Gadolinium-Based Contrast Agents Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Gadolinium-Based Contrast Agents Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
5.2 Global Gadolinium-Based Contrast Agents Revenue by Application
5.2.1 Global Gadolinium-Based Contrast Agents Historical Revenue by Application (2018-2024)
5.2.2 Global Gadolinium-Based Contrast Agents Forecasted Revenue by Application (2024-2034)
5.2.3 Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
5.3 Global Gadolinium-Based Contrast Agents Price by Application
5.3.1 Global Gadolinium-Based Contrast Agents Price by Application (2018-2024)
5.3.2 Global Gadolinium-Based Contrast Agents Price Forecast by Application (2024-2034)
6 North America
6.1 North America Gadolinium-Based Contrast Agents Sales by Company
6.1.1 North America Gadolinium-Based Contrast Agents Revenue by Company (2018-2024)
6.1.2 North America Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024)
6.2 North America Gadolinium-Based Contrast Agents Market Size by Type
6.2.1 North America Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2034)
6.2.2 North America Gadolinium-Based Contrast Agents Revenue by Type (2018-2034)
6.3 North America Gadolinium-Based Contrast Agents Market Size by Application
6.3.1 North America Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2034)
6.3.2 North America Gadolinium-Based Contrast Agents Revenue by Application (2018-2034)
6.4 North America Gadolinium-Based Contrast Agents Market Size by Country
6.4.1 North America Gadolinium-Based Contrast Agents Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Gadolinium-Based Contrast Agents Revenue by Country (2018-2034)
6.4.3 North America Gadolinium-Based Contrast Agents Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gadolinium-Based Contrast Agents Sales by Company
7.1.1 Europe Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024)
7.1.2 Europe Gadolinium-Based Contrast Agents Revenue by Company (2018-2024)
7.2 Europe Gadolinium-Based Contrast Agents Market Size by Type
7.2.1 Europe Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2034)
7.2.2 Europe Gadolinium-Based Contrast Agents Revenue by Type (2018-2034)
7.3 Europe Gadolinium-Based Contrast Agents Market Size by Application
7.3.1 Europe Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2034)
7.3.2 Europe Gadolinium-Based Contrast Agents Revenue by Application (2018-2034)
7.4 Europe Gadolinium-Based Contrast Agents Market Size by Country
7.4.1 Europe Gadolinium-Based Contrast Agents Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Gadolinium-Based Contrast Agents Revenue by Country (2018-2034)
7.4.3 Europe Gadolinium-Based Contrast Agents Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Gadolinium-Based Contrast Agents Sales by Company
8.1.1 China Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024)
8.1.2 China Gadolinium-Based Contrast Agents Revenue by Company (2018-2024)
8.2 China Gadolinium-Based Contrast Agents Market Size by Type
8.2.1 China Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2034)
8.2.2 China Gadolinium-Based Contrast Agents Revenue by Type (2018-2034)
8.3 China Gadolinium-Based Contrast Agents Market Size by Application
8.3.1 China Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2034)
8.3.2 China Gadolinium-Based Contrast Agents Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Gadolinium-Based Contrast Agents Sales by Company
9.1.1 APAC Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024)
9.1.2 APAC Gadolinium-Based Contrast Agents Revenue by Company (2018-2024)
9.2 APAC Gadolinium-Based Contrast Agents Market Size by Type
9.2.1 APAC Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2034)
9.2.2 APAC Gadolinium-Based Contrast Agents Revenue by Type (2018-2034)
9.3 APAC Gadolinium-Based Contrast Agents Market Size by Application
9.3.1 APAC Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2034)
9.3.2 APAC Gadolinium-Based Contrast Agents Revenue by Application (2018-2034)
9.4 APAC Gadolinium-Based Contrast Agents Market Size by Region
9.4.1 APAC Gadolinium-Based Contrast Agents Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Gadolinium-Based Contrast Agents Revenue by Region (2018-2034)
9.4.3 APAC Gadolinium-Based Contrast Agents Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales by Company
10.1.1 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Market Size by Type
10.2.1 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Market Size by Application
10.3.1 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Market Size by Country
10.4.1 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Overview
11.1.3 GE Healthcare Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GE Healthcare Gadolinium-Based Contrast Agents Products and Services
11.1.5 GE Healthcare Gadolinium-Based Contrast Agents SWOT Analysis
11.1.6 GE Healthcare Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Bayer Gadolinium-Based Contrast Agents Products and Services
11.2.5 Bayer Gadolinium-Based Contrast Agents SWOT Analysis
11.2.6 Bayer Recent Developments
11.3 Bracco Imaging
11.3.1 Bracco Imaging Company Information
11.3.2 Bracco Imaging Overview
11.3.3 Bracco Imaging Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Bracco Imaging Gadolinium-Based Contrast Agents Products and Services
11.3.5 Bracco Imaging Gadolinium-Based Contrast Agents SWOT Analysis
11.3.6 Bracco Imaging Recent Developments
11.4 Guerbet Group
11.4.1 Guerbet Group Company Information
11.4.2 Guerbet Group Overview
11.4.3 Guerbet Group Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Guerbet Group Gadolinium-Based Contrast Agents Products and Services
11.4.5 Guerbet Group Gadolinium-Based Contrast Agents SWOT Analysis
11.4.6 Guerbet Group Recent Developments
11.5 Hengrui Medicine
11.5.1 Hengrui Medicine Company Information
11.5.2 Hengrui Medicine Overview
11.5.3 Hengrui Medicine Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Hengrui Medicine Gadolinium-Based Contrast Agents Products and Services
11.5.5 Hengrui Medicine Gadolinium-Based Contrast Agents SWOT Analysis
11.5.6 Hengrui Medicine Recent Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Overview
11.6.3 Lantheus Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Lantheus Gadolinium-Based Contrast Agents Products and Services
11.6.5 Lantheus Gadolinium-Based Contrast Agents SWOT Analysis
11.6.6 Lantheus Recent Developments
11.7 YRPG
11.7.1 YRPG Company Information
11.7.2 YRPG Overview
11.7.3 YRPG Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 YRPG Gadolinium-Based Contrast Agents Products and Services
11.7.5 YRPG Gadolinium-Based Contrast Agents SWOT Analysis
11.7.6 YRPG Recent Developments
11.8 BeiLu Pharma
11.8.1 BeiLu Pharma Company Information
11.8.2 BeiLu Pharma Overview
11.8.3 BeiLu Pharma Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 BeiLu Pharma Gadolinium-Based Contrast Agents Products and Services
11.8.5 BeiLu Pharma Gadolinium-Based Contrast Agents SWOT Analysis
11.8.6 BeiLu Pharma Recent Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Information
11.9.2 Jiangsu Hengrui Medicine Overview
11.9.3 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Products and Services
11.9.5 Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents SWOT Analysis
11.9.6 Jiangsu Hengrui Medicine Recent Developments
11.10 Marotrast
11.10.1 Marotrast Company Information
11.10.2 Marotrast Overview
11.10.3 Marotrast Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Marotrast Gadolinium-Based Contrast Agents Products and Services
11.10.5 Marotrast Gadolinium-Based Contrast Agents SWOT Analysis
11.10.6 Marotrast Recent Developments
11.11 Agfa
11.11.1 Agfa Company Information
11.11.2 Agfa Overview
11.11.3 Agfa Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Agfa Gadolinium-Based Contrast Agents Products and Services
11.11.5 Agfa Recent Developments
11.12 Stary
11.12.1 Stary Company Information
11.12.2 Stary Overview
11.12.3 Stary Gadolinium-Based Contrast Agents Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Stary Gadolinium-Based Contrast Agents Products and Services
11.12.5 Stary Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Gadolinium-Based Contrast Agents Value Chain Analysis
12.2 Gadolinium-Based Contrast Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gadolinium-Based Contrast Agents Production Mode & Process
12.4 Gadolinium-Based Contrast Agents Sales and Marketing
12.4.1 Gadolinium-Based Contrast Agents Sales Channels
12.4.2 Gadolinium-Based Contrast Agents Distributors
12.5 Gadolinium-Based Contrast Agents Customers
13 Market Dynamics
13.1 Gadolinium-Based Contrast Agents Industry Trends
13.2 Gadolinium-Based Contrast Agents Market Drivers
13.3 Gadolinium-Based Contrast Agents Market Challenges
13.4 Gadolinium-Based Contrast Agents Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Linear Gadolinium-Based Contrast Agents
Table 3. Major Manufacturers of Macrocycle Gadolinium-Based Contrast Agents
Table 4. Global Gadolinium-Based Contrast Agents Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Gadolinium-Based Contrast Agents Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Gadolinium-Based Contrast Agents Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2018-2024)
Table 8. Global Gadolinium-Based Contrast Agents Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region (2024-2034)
Table 10. Global Gadolinium-Based Contrast Agents Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Gadolinium-Based Contrast Agents Sales by Region (2018-2024) & (K Units)
Table 12. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2018-2024)
Table 13. Global Gadolinium-Based Contrast Agents Sales by Region (2024-2034) & (K Units)
Table 14. Global Gadolinium-Based Contrast Agents Sales Market Share by Region (2024-2034)
Table 15. Global Gadolinium-Based Contrast Agents Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Gadolinium-Based Contrast Agents Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Gadolinium-Based Contrast Agents Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Gadolinium-Based Contrast Agents Revenue Share by Manufacturers (2018-2024)
Table 19. Global Gadolinium-Based Contrast Agents Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Gadolinium-Based Contrast Agents, Industry Ranking, 2021 VS 2022
Table 21. Global Gadolinium-Based Contrast Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Gadolinium-Based Contrast Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gadolinium-Based Contrast Agents as of 2022)
Table 23. Global Key Manufacturers of Gadolinium-Based Contrast Agents, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Gadolinium-Based Contrast Agents, Product Offered and Application
Table 25. Global Key Manufacturers of Gadolinium-Based Contrast Agents, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Gadolinium-Based Contrast Agents Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Gadolinium-Based Contrast Agents Sales Quantity Share by Type (2018-2024)
Table 30. Global Gadolinium-Based Contrast Agents Sales Quantity Share by Type (2024-2034)
Table 31. Global Gadolinium-Based Contrast Agents Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Gadolinium-Based Contrast Agents Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Gadolinium-Based Contrast Agents Revenue Share by Type (2018-2024)
Table 34. Global Gadolinium-Based Contrast Agents Revenue Share by Type (2024-2034)
Table 35. Gadolinium-Based Contrast Agents Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Gadolinium-Based Contrast Agents Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Gadolinium-Based Contrast Agents Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Gadolinium-Based Contrast Agents Sales Quantity Share by Application (2018-2024)
Table 40. Global Gadolinium-Based Contrast Agents Sales Quantity Share by Application (2024-2034)
Table 41. Global Gadolinium-Based Contrast Agents Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Gadolinium-Based Contrast Agents Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Gadolinium-Based Contrast Agents Revenue Share by Application (2018-2024)
Table 44. Global Gadolinium-Based Contrast Agents Revenue Share by Application (2024-2034)
Table 45. Gadolinium-Based Contrast Agents Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Gadolinium-Based Contrast Agents Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Gadolinium-Based Contrast Agents Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Gadolinium-Based Contrast Agents Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Gadolinium-Based Contrast Agents Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Gadolinium-Based Contrast Agents Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Gadolinium-Based Contrast Agents Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Gadolinium-Based Contrast Agents Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Gadolinium-Based Contrast Agents Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Gadolinium-Based Contrast Agents Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Gadolinium-Based Contrast Agents Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Gadolinium-Based Contrast Agents Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Gadolinium-Based Contrast Agents Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Gadolinium-Based Contrast Agents Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Gadolinium-Based Contrast Agents Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Gadolinium-Based Contrast Agents Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Gadolinium-Based Contrast Agents Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Gadolinium-Based Contrast Agents Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Gadolinium-Based Contrast Agents Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Gadolinium-Based Contrast Agents Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Gadolinium-Based Contrast Agents Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Gadolinium-Based Contrast Agents Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Gadolinium-Based Contrast Agents Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Gadolinium-Based Contrast Agents Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Gadolinium-Based Contrast Agents Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Gadolinium-Based Contrast Agents Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Gadolinium-Based Contrast Agents Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Gadolinium-Based Contrast Agents Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Gadolinium-Based Contrast Agents Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Gadolinium-Based Contrast Agents Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Gadolinium-Based Contrast Agents Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Gadolinium-Based Contrast Agents Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Gadolinium-Based Contrast Agents Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Gadolinium-Based Contrast Agents Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Gadolinium-Based Contrast Agents Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Gadolinium-Based Contrast Agents Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Gadolinium-Based Contrast Agents Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Gadolinium-Based Contrast Agents Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Gadolinium-Based Contrast Agents Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Gadolinium-Based Contrast Agents Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Gadolinium-Based Contrast Agents Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Gadolinium-Based Contrast Agents Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Gadolinium-Based Contrast Agents Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Gadolinium-Based Contrast Agents Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Gadolinium-Based Contrast Agents Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity by Country (2024-2034) & (K Units)
Table 117. GE Healthcare Company Information
Table 118. GE Healthcare Description and Overview
Table 119. GE Healthcare Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. GE Healthcare Gadolinium-Based Contrast Agents Product and Services
Table 121. GE Healthcare Gadolinium-Based Contrast Agents SWOT Analysis
Table 122. GE Healthcare Recent Developments
Table 123. Bayer Company Information
Table 124. Bayer Description and Overview
Table 125. Bayer Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Bayer Gadolinium-Based Contrast Agents Product and Services
Table 127. Bayer Gadolinium-Based Contrast Agents SWOT Analysis
Table 128. Bayer Recent Developments
Table 129. Bracco Imaging Company Information
Table 130. Bracco Imaging Description and Overview
Table 131. Bracco Imaging Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Bracco Imaging Gadolinium-Based Contrast Agents Product and Services
Table 133. Bracco Imaging Gadolinium-Based Contrast Agents SWOT Analysis
Table 134. Bracco Imaging Recent Developments
Table 135. Guerbet Group Company Information
Table 136. Guerbet Group Description and Overview
Table 137. Guerbet Group Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Guerbet Group Gadolinium-Based Contrast Agents Product and Services
Table 139. Guerbet Group Gadolinium-Based Contrast Agents SWOT Analysis
Table 140. Guerbet Group Recent Developments
Table 141. Hengrui Medicine Company Information
Table 142. Hengrui Medicine Description and Overview
Table 143. Hengrui Medicine Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Hengrui Medicine Gadolinium-Based Contrast Agents Product and Services
Table 145. Hengrui Medicine Gadolinium-Based Contrast Agents SWOT Analysis
Table 146. Hengrui Medicine Recent Developments
Table 147. Lantheus Company Information
Table 148. Lantheus Description and Overview
Table 149. Lantheus Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Lantheus Gadolinium-Based Contrast Agents Product and Services
Table 151. Lantheus Gadolinium-Based Contrast Agents SWOT Analysis
Table 152. Lantheus Recent Developments
Table 153. YRPG Company Information
Table 154. YRPG Description and Overview
Table 155. YRPG Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. YRPG Gadolinium-Based Contrast Agents Product and Services
Table 157. YRPG Gadolinium-Based Contrast Agents SWOT Analysis
Table 158. YRPG Recent Developments
Table 159. BeiLu Pharma Company Information
Table 160. BeiLu Pharma Description and Overview
Table 161. BeiLu Pharma Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. BeiLu Pharma Gadolinium-Based Contrast Agents Product and Services
Table 163. BeiLu Pharma Gadolinium-Based Contrast Agents SWOT Analysis
Table 164. BeiLu Pharma Recent Developments
Table 165. Jiangsu Hengrui Medicine Company Information
Table 166. Jiangsu Hengrui Medicine Description and Overview
Table 167. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents Product and Services
Table 169. Jiangsu Hengrui Medicine Gadolinium-Based Contrast Agents SWOT Analysis
Table 170. Jiangsu Hengrui Medicine Recent Developments
Table 171. Marotrast Company Information
Table 172. Marotrast Description and Overview
Table 173. Marotrast Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. Marotrast Gadolinium-Based Contrast Agents Product and Services
Table 175. Marotrast Gadolinium-Based Contrast Agents SWOT Analysis
Table 176. Marotrast Recent Developments
Table 177. Agfa Company Information
Table 178. Agfa Description and Overview
Table 179. Agfa Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 180. Agfa Gadolinium-Based Contrast Agents Product and Services
Table 181. Agfa Recent Developments
Table 182. Stary Company Information
Table 183. Stary Description and Overview
Table 184. Stary Gadolinium-Based Contrast Agents Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 185. Stary Gadolinium-Based Contrast Agents Product and Services
Table 186. Stary Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Gadolinium-Based Contrast Agents Distributors List
Table 190. Gadolinium-Based Contrast Agents Customers List
Table 191. Gadolinium-Based Contrast Agents Market Trends
Table 192. Gadolinium-Based Contrast Agents Market Drivers
Table 193. Gadolinium-Based Contrast Agents Market Challenges
Table 194. Gadolinium-Based Contrast Agents Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Gadolinium-Based Contrast Agents Product Picture
Figure 2. Global Gadolinium-Based Contrast Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gadolinium-Based Contrast Agents Market Share by Type in 2022 & 2034
Figure 4. Linear Gadolinium-Based Contrast Agents Product Picture
Figure 5. Macrocycle Gadolinium-Based Contrast Agents Product Picture
Figure 6. Global Gadolinium-Based Contrast Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Gadolinium-Based Contrast Agents Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Specialist Clinic
Figure 10. Others
Figure 11. Gadolinium-Based Contrast Agents Report Years Considered
Figure 12. Global Gadolinium-Based Contrast Agents Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Gadolinium-Based Contrast Agents Revenue 2018-2034 (US$ Million)
Figure 14. Global Gadolinium-Based Contrast Agents Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Gadolinium-Based Contrast Agents Sales Quantity 2018-2034 (K Units)
Figure 16. Global Gadolinium-Based Contrast Agents Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Gadolinium-Based Contrast Agents Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Gadolinium-Based Contrast Agents Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Gadolinium-Based Contrast Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Gadolinium-Based Contrast Agents Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Gadolinium-Based Contrast Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Gadolinium-Based Contrast Agents Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Gadolinium-Based Contrast Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Gadolinium-Based Contrast Agents Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Gadolinium-Based Contrast Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Gadolinium-Based Contrast Agents Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Gadolinium-Based Contrast Agents Revenue in 2022
Figure 30. Gadolinium-Based Contrast Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
Figure 33. Global Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
Figure 35. North America Gadolinium-Based Contrast Agents Revenue Market Share by Company in 2022
Figure 36. North America Gadolinium-Based Contrast Agents Sales Quantity Market Share by Company in 2022
Figure 37. North America Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
Figure 39. North America Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
Figure 41. North America Gadolinium-Based Contrast Agents Revenue Share by Country (2018-2034)
Figure 42. North America Gadolinium-Based Contrast Agents Sales Quantity Share by Country (2018-2034)
Figure 43. United States Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Gadolinium-Based Contrast Agents Sales Quantity Market Share by Company in 2022
Figure 46. Europe Gadolinium-Based Contrast Agents Revenue Market Share by Company in 2022
Figure 47. Europe Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
Figure 49. Europe Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
Figure 51. Europe Gadolinium-Based Contrast Agents Revenue Share by Country (2018-2034)
Figure 52. Europe Gadolinium-Based Contrast Agents Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 54. France Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 58. China Gadolinium-Based Contrast Agents Sales Quantity Market Share by Company in 2022
Figure 59. China Gadolinium-Based Contrast Agents Revenue Market Share by Company in 2022
Figure 60. China Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
Figure 62. China Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
Figure 64. APAC Gadolinium-Based Contrast Agents Sales Quantity Market Share by Company in 2022
Figure 65. APAC Gadolinium-Based Contrast Agents Revenue Market Share by Company in 2022
Figure 66. APAC Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
Figure 68. APAC Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
Figure 70. APAC Gadolinium-Based Contrast Agents Revenue Share by Region (2018-2034)
Figure 71. APAC Gadolinium-Based Contrast Agents Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 76. India Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Gadolinium-Based Contrast Agents Revenue Share by Country (2018-2034)
Figure 85. Brazil Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Gadolinium-Based Contrast Agents Revenue (2018-2034) & (US$ Million)
Figure 90. Gadolinium-Based Contrast Agents Value Chain
Figure 91. Gadolinium-Based Contrast Agents Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed